National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
More NCI Dictionaries
Dictionary of Cancer Terms

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

atomoxetine hydrochloride
The hydrochloride salt of atomoxetine, a phenoxy-3-propylamine derivative and selective non-stimulant, norepinephrine reuptake inhibitor with cognitive-enhancing activity. Although its precise mechanism of action is unknown, atomoxetine appears to selectively inhibit the pre-synaptic norepinephrine transporter, resulting in inhibition of the presynaptic reabsorption of norepinephrine and prolongation of norepinephrine activity in the synaptic cleft; the effect on cognitive brain function may result in improved attention and decreased impulsivity and activity levels. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

US brand name:Strattera
Chemical structure names:
  • (-)-N -methyl-3-phenyl-3-(o-tolyloxy)-propylamine hydrochloride
  • (-)-N-methyl-gamma(2-methylphenoxy)benzenepropamine Hydrochloride



Previous:ATGAM, Athrombin-K, atiprimod, Ativan, ATN-161
Next:atorvastatin calcium, Atragen, atrasentan hydrochloride, Atromid-S, atvogen

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov